Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
AI: An Endless Opportunity or Existential Threat?
Tickers AAPL GOOGL ICAD IRBT
Tags Stocks to Buy WMT AAPL
From InvestorPlace
Why Shares of Zentalis Pharmaceuticals Dropped This Week
Tickers RHHBY ZNTL
Tags Recent Press Releases Market News ZNTL
From Motley Fool
Why Shares of Rain Oncology Are Plummeting Today
Tickers RAIN RHHBY
Tags RHHBY RAIN Market News
From Motley Fool
Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories
Tickers ABBV AZN BCS CS
Tags BCS Market News UBS
From Benzinga
Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
Tickers MKGAF RHHBF RHHBY RHHVF
Tags MKGAF Biotech Market News
From Benzinga
AI Meets Biotech: Transforming the Drug Development Process
Tickers AZN BAYRY RHHBY SNY
Tags BAYRY OTCMKTS:BAYRY,OTCMKTS:RHHBY,Nasdaq:SNY,Nasdaq:AZN SNY
From InvestorPlace
3 Stocks That Are Reshaping the Future
Tickers MSFT RHHBY ZBH
Tags ZBH RHHBY MSFT
From InvestorPlace
3 Personalized Medicine Stocks to Buy for Long-Time Returns
Tickers ADPT EXAS GSK ME
Tags Stocks to Buy ME EXAS
From InvestorPlace
EXCLUSIVE: SAB Biotherapeutics' Influenza Immunotherapy Shows Safety, Efficacy In Early-Stage Trials
Tickers RHHBY SABS
Tags Penny Stocks Market News Biotech
From Benzinga
Tempest Therapeutics' TPST-1120 Shines In Early Phase 1b/2 Study: Analysts Get Bullish
Tickers RHHBY TPST
Tags Movers Benzinga TPST
From Benzinga
Roche's Q1 Highlights: Increased Uptake Of Eye Disease Drug Cushions Sales Decline
Tickers RHHBF RHHBY RHHVF
Tags General News Large Cap
From Benzinga
EXCLUSIVE: SAB Biotherapeutics Releases Topline Data From Discontinued COVID Antibody Trial
Tickers REGN RHHBY SABS
Tags RHHBY Penny Stocks REGN
From Benzinga
3 Top Biotech Stocks Defying the Bear Market
Tickers BGNE BIIB LLY NVS
Tags RHHBY LLY BIIB
From Motley Fool
This Company's Non-Invasive Tech Looks To Be Unique In the Market And Can Help People Take Ownership Over Monitoring Their Health
Tickers ABT DXCM RHHBY TECH
Tags Tech RHHBY ABT
From Benzinga
FDA Approves Roche's Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma
Tickers RHHBF RHHBY RHHVF
Tags RHHBY RHHVF Health Care
From Benzinga
EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics' Influenza Antibody
Tickers RHHBF RHHBY RHHVF SABS
Tags Penny Stocks Biotech Market News
From Benzinga
Why Shares of Adaptimmune Therapeutics Jumped Tuesday
Tickers ADAP GSK RHHBY
Tags ADAP RHHBY Recent Press Releases
From Motley Fool
Bolt Biotherapeutics Says Phase 1 Data Supports Advancing Into Phase 2 Studies
Tickers BMY BOLT RHHBY
Tags Briefs News General
From Benzinga
Roche's Slow Growth Shouldn't Drive Investors Away
Tickers RHHBY
Tags Market News Recent Press Releases RHHBY
From Motley Fool
Roche Joins Hand With Lilly To Improve Early Diagnosis Of Alzheimer's Disease
Tickers LLY RHHBY
Tags Benzinga Briefs News
From Benzinga
New Four Year Data For Roche's Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients
Tickers RHHBF RHHBY RHHVF
Tags Market News Biotech Eurasia
From Benzinga
Is Roche a Buy Now?
Tickers RHHBY
Tags RHHBY Market News Recent Press Releases
From Motley Fool
Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy
Tickers RHHBY SRPT
Tags Market News Biotech SRPT
From Benzinga
FDA Casts Doubts Over Roche's Polivy Label Expansion For Untreated Lymphoma Setting
Tickers RHHBF RHHBY RHHVF
Tags News Large Cap Briefs
From Benzinga
The Top 7 Growth Stocks in Biotech
Tickers APVO BEAM CMRX DVAX
Tags ITOS Market News VIR
From InvestorPlace
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
Tickers EXEL RHHBF RHHBY RHHVF
Tags RHHBY Health Care RHHVF
From Benzinga
Why Sarepta Therapeutics' Shares Rose 23.4% This Week
Tickers RHHBY SRPT
Tags SRPT Market News Recent Press Releases
From Motley Fool
3 Best Growth Stocks to Buy In March
Tickers HIMS IWF MELI RHHBY
Tags Recent Press Releases Market News SRPT
From Motley Fool
Blueprint Medicines Highlights Detailed Data From Lead Product In Blood Cancer Patients
Tickers BPMC RHHBY
Tags RHHBY Health Care Market News
From Benzinga
Roche Decides To Terminate Cancer Treatment Pact With Blueprint Medicines
Tickers BPMC RHHBF RHHBY RHHVF
Tags Benzinga BPMC Briefs
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.